Tag Archives | News

Indalo Therapeutics Presents Phase 1 Clinical Trial Results for Lead Antifibrotic Drug Candidate IDL-2965

Indalo

Demonstrates strong safety and oral PKData presented November 7, 2019 at PFF Summit, San Antonio, TX Cambridge, MA, November 11, 2019 – Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and nonalcoholic steatohepatitis (NASH), for the first time presented clinical data […]

Comments Off on Indalo Therapeutics Presents Phase 1 Clinical Trial Results for Lead Antifibrotic Drug Candidate IDL-2965 Continue Reading →

Capital M Podcast: KaloCyte President & CEO Elaine Haynes Discusses Business in Maryland

Kalocyte

The Capital M Podcast #LifeScienceRevolution: Proximity to Resources with KaloCyte. Listen to part 3 of the Capital M podcast, #LifeScienceRevolution: Proximity to Resources with KaloCyte. In this episode, MTC CEO Martin Rosendale discusses business in Maryland with Elaine E. Hayne, President and CEO of KaloCyte, Inc., a pre-clinical biotech startup developing a synthetic red blood cell substitute. Listen to the […]

Comments Off on Capital M Podcast: KaloCyte President & CEO Elaine Haynes Discusses Business in Maryland Continue Reading →

Cartesian Initiates CAR-T Clinical Trial in Myasthenia Gravis

Cartesian Logo New JPG

First CAR-T to enter clinical development for an autoimmune disease Descartes-08 engineered to have a defined, predictable half-life, enabling repeat dosing to maximize potential for potency while minimizing risk of toxicity Gaithersburg, MD, November 5, 2019 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer and autoimmune diseases, today […]

Comments Off on Cartesian Initiates CAR-T Clinical Trial in Myasthenia Gravis Continue Reading →

BioBuzz: Pat Larrabee is Building the Biotech Infrastructure in the Capital Region and has been for Nearly 25 Years – Here’s What’s Next…

Pat2

The growth of the BioHealth Capital Region (BHCR) and its position as a global biohealth cluster is a hot topic of discussion—often filtered through a broad, conceptual lens focused on big-picture trends, GEN publication rankings and widely discussed areas of industry need. The development and growth of the BHCR is also a story that supports the life […]

Comments Off on BioBuzz: Pat Larrabee is Building the Biotech Infrastructure in the Capital Region and has been for Nearly 25 Years – Here’s What’s Next… Continue Reading →